FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

GlaxoSmithKline Sumatriptan Succinate Injection Recall

Sumatriptan Succinate Injection, 6 mg, 0

GlaxoSmithKline, LLC. · Zebulon, NC

Risk level
Class II
Reported by FDA
Jan 1, 2014
Recall ID
D-388-2014
Check your lot numberHow we source this data

Summary

GlaxoSmithKline recalled Sumatriptan Succinate Injection starting Nov 6, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-388-2014 on Jan 1, 2014. Reason: Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Product description

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.

Lot numbers, UPCs & expiration codes

Lot#: C636242, Exp: 06/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-388-2014
Classification
Class II
Status
Terminated
Recall initiated
Nov 6, 2013
FDA report date
Jan 1, 2014
Quantity
9,743 cartridges
Recall type
Voluntary: Firm initiated
Recalling firm
GlaxoSmithKline, LLC.

Original FDA data

Every field from FDA enforcement report D-388-2014, exactly as published.

Show all FDA fields
City
Zebulon
State
NC
Status
Terminated
Country
United States
Event ID
66988
Address
1011 North Arendell Ave
Code information
Lot#: C636242, Exp: 06/15
Postal code
27597-1217
Report date
Jan 1, 2014
Product type
Drugs
Recall number
D-388-2014
Classification
Class II
Recalling firm
GlaxoSmithKline, LLC.
Product quantity
9,743 cartridges
Termination date
Aug 20, 2014
Reason for recall
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.
Distribution pattern
Nationwide
Recall initiation date
Nov 6, 2013
Initial firm notification
Letter
Center classification date
Dec 24, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-388-2014, published Jan 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls